Osteopore signs three-year Middle East distribution deal
Share
- Osteopore signed a three-year distribution agreement with Al-Umnia Medical across five Middle Eastern countries.
- Following the announcement, Osteopore shares were unchanged at $0.005.
- The deal targets a GCC orthopaedic devices market forecasted to reach US$1.55 billion by 2034.
Osteopore (ASX:OSX) has secured a three-year distribution deal with Al-Umnia Medical across five Middle Eastern nations.
The agreement targets a regional market valued at US$897.5 million in 2025.
Under the contract, Al-Umnia will distribute products in Saudi Arabia, the UAE, Oman, Qatar, and Bahrain.
Both businesses will now begin product registration procedures to meet specific regulatory requirements in each jurisdiction.
Following the announcement, the Osteopore share price was unchanged at $0.005.
Industry data cited by the company forecasts the GCC orthopaedic market will reach US$1.55 billion by 2034.
Dubai-based Al-Umnia brings a workforce of over 70 employees to support expansion in synthetic bone substitutes.
